Buds & Duds: Canopy Growth slips as CEO warns of bubble for cannabis industry

Organigram advanced after announcing discounts on medical cannabis for low-income patients

A marijuana plant
Bruce Linton, CEO of Canopy Growth, says cannabis investors should be selective

Cannabis stocks in the US and Canada had a down day Wednesday, trading in the same direction as the S&P/TSX Composite Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 0.4% to 259.86.


Canopy Growth Corp (NYSE:CGC) (TSE:WEED) dropped 0.5% to US$43.45 in New York trading after CEO  Bruce Linton told CNBC at the World Economic Forum in Davos, Switzerland, that the cannabis industry faces a "massive inflationary bubble" and that investors should be careful.

"Everybody wants to be in the cannabis space, and I think investors have to be selective because … there will be a new name every week," Linton said.

READ: Canada's Canopy Growth shares bloom as it receives license to develop industrial hemp in New York

Merger speculation sank Aphria Inc (NYSE:APHA) (TSE:APHA). Its stock fell 2.3% to US$6.92 in New York on Wednesday after advising shareholders to take no action until its board has made a recommendation regarding an unsolicited takeover offer from Green Growth Brands Inc. (OTCMKTS:GGBXF) (CSE:GGB).

The agreement could value the Canadian cannabis company at  C$2.35 billion (US$1.76 billion).

In December, Aphria rejected Green Growth’s takeover bid on the grounds that it significantly undervalued the company.

Aphria fell 2.1% to C$9.23 in Canadian trading. Green Growth declined 2.3% to US$4.37 on the OTC Markets and was down 2.8% to C$5.81 in Canada.

Hexo Corp (TSE:HEXO) slipped 2.1% to C$6.92 in Toronto after earlier this week announcing a proposed offering of common shares of C$50 million (US$37 million).

In September, Riposte Capital, which owned 2.5% of the cannabis company, urged it to explore more deals.


The Green Organic Dutchman Holdings (TSE:TGOD) (OTCQX:TGODF) shares climbed, up 2.7% at C$3.05.

Last week, the company announced it had tapped Dr Rav Kumar as its chief scientific officer.

Organigram Holdings Inc (OTCMKTS:OGRMF) (CVE:OGI) shares were up 0.2% to US$4.69 in OTC Markets trading after the licensed cannabis producer announced OrganiCare, a program designed to improve access to medical cannabis for low-income patients.

Effective immediately, patients who earn an annual income less than C$35,000 per year qualify for a 30% price reduction on dried cannabis products and oils, the New Brunswick company said.

The stock advanced 1.6% to C$6.26 in Canadian trading.

Contact Dennis Fitzgerald at [email protected]

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bragg Gaming showing support for potential new Canadian law allowing Single...

Bragg Gaming Group (CVE: BRAG- OTC: BRGGF) Chief Strategy Officer Yaniv Spielberg joined Steve Darling from Proactive with news the company is very supportive of new legislation put forward by the Canadian Government that, if passed, would allow single-game betting in Canada. Spielberg...

3 hours, 58 minutes ago

2 min read